CPRX
Catalyst Pharmaceuticals
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: CPRX
- PE Ratio
The current P/E ratio for Catalyst Pharmaceuticals stock as of Jun 23, 2026 is 17.35. This is calculated based on the current EPS of $1.81 and the stock price of $31.4 per share. The PE ratio has increased by 37% from the past four quarters average of 12.6.
CPRX PE ratio history
The average historical PE ratio of Catalyst Pharmaceuticals for the last seven years is 16.49. The current price-to-earnings ratio of 17.35 is 5% more than the historical average. In the past seven years, CPRX's PE ratio reached its highest point in the Sep 2019 quarter at 59, when the stock price was $5.31 and the EPS was $0.09. The lowest point was recorded in the Sep 2020 quarter, when it reached 4.3 with a price of $2.97 and an EPS of $0.69.
Catalyst Pharmaceuticals PE ratio by year
Maximum annual increase: 284.05% in 2021
Maximum annual decrease: -61.65% in 2020
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 13.34 | -11.77% | $23.34 | $1.75 |
| 2024 | 15.12 | -39.74% | $20.87 | $1.38 |
| 2023 | 25.09 | 7.91% | $16.81 | $0.67 |
| 2022 | 23.25 | 30.47% | $18.6 | $0.8 |
| 2021 | 17.82 | 284.05% | $6.77 | $0.38 |
| 2020 | 4.64 | -61.65% | $3.34 | $0.72 |
| 2019 | 12.1 | N/A | $3.75 | $0.31 |
| 2018 | N/A | N/A | $1.92 | -$0.33 |
| 2017 | N/A | N/A | $3.91 | -$0.21 |
| 2016 | N/A | N/A | $1.05 | -$0.22 |
| 2015 | N/A | N/A | $2.45 | -$0.25 |
| 2014 | N/A | N/A | $2.97 | -$0.24 |
| 2013 | N/A | N/A | $1.95 | -$0.27 |
| 2012 | N/A | N/A | $0.44 | -$0.14 |
| 2011 | N/A | N/A | $1.29 | -$0.29 |
Catalyst Pharmaceuticals PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 13.68 | 2.55% | $24.76 | $1.81 |
| Dec 2025 | 13.34 | 21.16% | $23.34 | $1.75 |
| Sep 2025 | 11.01 | -12.2% | $19.7 | $1.79 |
| Jun 2025 | 12.54 | -14.69% | $21.7 | $1.73 |
| Mar 2025 | 14.7 | -2.78% | $24.25 | $1.65 |
| Dec 2024 | 15.12 | -4.91% | $20.87 | $1.38 |
| Sep 2024 | 15.9 | -39.43% | $19.88 | $1.25 |
| Jun 2024 | 26.25 | -1.2% | $15.49 | $0.59 |
| Mar 2024 | 26.57 | 5.9% | $15.94 | $0.6 |
| Dec 2023 | 25.09 | 26.65% | $16.81 | $0.67 |
| Sep 2023 | 19.81 | 62.11% | $11.69 | $0.59 |
| Jun 2023 | 12.22 | -29.97% | $13.44 | $1.1 |
| Mar 2023 | 17.45 | -24.95% | $16.58 | $0.95 |
| Dec 2022 | 23.25 | 17.78% | $18.6 | $0.8 |
| Sep 2022 | 19.74 | 49.21% | $12.83 | $0.65 |
CPRX Price vs fair value
CPRX average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
The current PE ratio of CPRX is above its 3, 5 and 10-year historical averages.
PE comparison
Catalyst Pharmaceuticals's P/E of 17.35 is above the industry average but below the Healthcare sector and its peers average. Looking at its Healthcare sector average of 23.78, Catalyst Pharmaceuticals's P/E is 27% lower.
CPRX PE vs peers
When compared to its peer stocks JNJ and ABT, CPRX's PE ratio is lower. Catalyst Pharmaceuticals is presently trading at a lower PE ratio (17.35) than its peer group average of 28.12.
| Stock name | PE ratio | Market cap |
|---|---|---|
| CPRX Catalyst Pharmaceuticals Inc | 17.35 | $3.84B |
| PFE Pfizer Inc | 18.87 | $140.89B |
| ABT Abbott Laboratories | 25.22 | $157.69B |
| JNJ Johnson & Johnson | 27.39 | $575.52B |
| SRPT Sarepta Therapeutics Inc | 28.77 | $1.82B |
| BMRN Biomarin Pharmaceutical Inc | 40.36 | $10.92B |
Frequently asked questions
What is Catalyst Pharmaceuticals's PE ratio?
CPRX stock has a price to earnings ratio of 17.35 as of Jun 23, 2026.
What is the 3-year average PE ratio for Catalyst Pharmaceuticals (CPRX)?
As an average over the last 3 years, CPRX stock has a PE ratio of 17.19.
What is the 5-year average PE ratio for Catalyst Pharmaceuticals (CPRX)?
As an average over the last 5 years, CPRX stock has a PE ratio of 16.89.
What is the highest PE ratio for CPRX?
Over the last seven years, the quarterly PE ratio reached a historic high of 59 in the Sep 2019 quarter.
How does the current PE ratio for CPRX compare to its historical average?
The current price to earnings ratio of CPRX is 5% higher than the 7-year historical average.
How is CPRX's PE ratio calculated (Catalyst Pharmaceuticals PE ratio formula)?
The P/E ratio is calculated by taking the latest stock price and dividing it by the earnings per share(EPS) for the last 12 months. As of today (Jun 23, 2026), Catalyst Pharmaceuticals's stock price is $31.4. The earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $1.81. Therefore, Catalyst Pharmaceuticals's price to earnings ratio for today is 17.35. PE RATIO(17.35) = STOCK PRICE($31.4) / TTM EPS($1.81)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.